Today’s tone
- 52 weeks
- 229.40 dollars
▼
$ 398.35
- Profit
- 2.48 %
- P/E ratio.
- 18.99
- The target price
- 309.25 dollars
The pain of the international consulting company Nyse: acn2025 was a difficult year. The stocks provided a total return of about 33 % as of the closure of September 25. This inventory was placed in a multiple historical low assessment. In fact, the front price of Acceneture (P/E) of 17x is the lowest in three years. This indicates a strong opportunity for the arrow to recover, especially with the prosperity of his business in Genai.
However, given the market morale and the latest profits of the company, is Accenture really playing value, or a train anywhere at the present time?
ACN excels, but the instructions lead the stocks down
On September 25, Acceneture released the financial results of Q4 and the results of 2025 complete. Compared to analysts estimates, the company’s financial statements were strong. In the fourth quarter, revenues grew to $ 17.60 billion, an increase of 7.3 % over the previous year. These expectations have won a moderate manner over $ 17.34 billion, or 5.7 % growth.
EPS (EPS) profits (EPS) reached $ 3.03, which grows by 8.6 %. This was the best 5 cents from the expected $ 2.98, or a growth rate of 6.8 %. Nevertheless, the inventory was almost 3 % sold as a reaction to the results.
This is mainly due to the 2026 financial access instructions, which are weak markets. The company believes that the revenues are increasing by 2 % to 5 % in the local currency, and the projects were modified for the arrow’s profit from $ 13.71 at the center point.
Analysts were looking for $ 13.78. However, after modifying the EPS Q4, the company’s 2026 EPS guidelines are only in cents less than expected. Selling the moderate to the share is logical given this. Now, let’s take a deeper look at some basic scales in Accenture.
Reservation growth recovers, Genai continues strong contributions
One of the decisive positivity of the Q4 of Accenture is that the new reservations amounted to 21.3 billion dollars, an increase of 6 % in the US dollar. The reservations are a major indication of the capabilities of future revenues, which reflects the contracts signed by the company, but they have not yet obtained revenues from them.
This growth was a major shift from the previous quarters. In the Q2 fiscal year, reservations decreased by 3 % and decreased by more than 6 % in the financial Q3. Nevertheless, reservation numbers indicate stability instead of explicit recovery. Accenture says it “has not seen any useful, positive or negative change” in its public market.
However, the acceleration in the growth of the company’s Genai’s reservations was impressive. They moved up to $ 1.8 billion from $ 1.5 billion in the third quarter. In general, the company’s Genai’s reservations amounted to $ 5.9 billion in the fiscal year 2025, and each quarter accelerates.
This exceeds moderately $ 5.5 billion of Genai’s reservations in international business machines, the technology sector competing New York: IBM Over the past four.
It is worth noting that the modified operating margin in Acceneture increased by 10 basis points per quarter and in the full year. Although this slight expansion is not a great sign, it is also better than what one might expect, given the dramatic decrease in the Accenture share price.
Analysts see 25 % of the upward trend, but the feelings continue to be weak
Accenture stocks today
321.33 dollars
38.39 % upModerate purchase
Based on 25 analyst classifications
| The current price | 232.20 dollars |
|---|---|
| High expectations | 420.00 dollars |
| Average expectations | 321.33 dollars |
| Low expectations | 240.00 dollars |
Accenture stocks details
Currently, the target Marketbeat consensus price on Acceneture is about 322 dollars. Compared to the closing price of September 25, this means a very large share of 39 %. However, the target updates of the last price paint a lower favorable picture.
The average goal updated from September 9 to September 24 is only $ 291. This number means about 25 % up in stocks. However, Wall Street and P/E expectations to reduce value to reduce. However, feelings on this name are still very low for several reasons.
First, Accenture goes through a great restructuring of her work. Because of this, the company expects a combined fee of $ 865 million in the fourth and second quarter of Q1 2026. It is because Acceneture turns its working power to get more GNAI capabilities. The company’s federal spending reduction in the company is also the main opposite wind.
Finally, many believe that although Genai is an increasing part of Acceneture, technology may harm it in the long run. As technology progresses, current customers can grow GENAI tools increasingly instead of Accessure to improve their business.
However, the development of GENAI also means that people’s understanding of technology will need development, which may create new areas where Acceenture can add value. It is still difficult to know how this dynamic will play, but a few of them take the Accene team.
In general, with feelings on Acceneture negatively negative, things may get worse for this arrow before they improve. Thus, something changes financially about how to see the market, it looks like a better name.
Before you think about Acceneture, you will want to hear this.
Marketbeat follows the best research analyst at Wall Street, the best performance in Wall Street and the stocks they recommend to their customers on a daily basis. Marketbeat has selected the five shares whose senior analysts are quietly whispered to their customers to buy now before hunting the broader market … and not Accenture was on the list.
While Accenture currently has a moderate purchase classification among analysts, higher -rated analysts believe that these five stocks buy better.
Show the five stocks here
Learn the basics of trading options and how to use them to enhance returns and manage risk through this free report from Marketbeat. Click on the link below to get your free copy.
